open access

Vol 76, No 6 (2018)
Editorials
Published online: 2018-06-11
Submitted: 2018-04-25
Accepted: 2018-04-25
Get Citation

Does prior percutaneous coronary intervention influence the outcome of coronary artery bypass grafting? One size does not fit all

Giampaolo Niccoli, Rocco A. Montone
DOI: 10.5603/KP.2018.0115
·
Kardiol Pol 2018;76(6):933-934.

open access

Vol 76, No 6 (2018)
Editorials
Published online: 2018-06-11
Submitted: 2018-04-25
Accepted: 2018-04-25

Abstract

Not available

Abstract

Not available
Get Citation
About this article
Title

Does prior percutaneous coronary intervention influence the outcome of coronary artery bypass grafting? One size does not fit all

Journal

Kardiologia Polska (Polish Heart Journal)

Issue

Vol 76, No 6 (2018)

Pages

933-934

Published online

2018-06-11

DOI

10.5603/KP.2018.0115

Bibliographic record

Kardiol Pol 2018;76(6):933-934.

Authors

Giampaolo Niccoli
Rocco A. Montone

References (14)
  1. Serruys PW, Morice MC, Kappetein AP, et al. SYNTAX Investigators. Percutaneous coronary intervention versus coronary-artery bypass grafting for severe coronary artery disease. N Engl J Med. 2009; 360(10): 961–972.
  2. Farkouh ME, Domanski M, Sleeper LA, et al. FREEDOM Trial Investigators. Strategies for multivessel revascularization in patients with diabetes. N Engl J Med. 2012; 367(25): 2375–2384.
  3. Stone G, Sabik J, Serruys P, et al. Everolimus-Eluting Stents or Bypass Surgery for Left Main Coronary Artery Disease. N Engl J Med. 2016; 375(23): 2223–2235.
  4. Roger VL, Go AS, Lloyd-Jones DM, et al. American Heart Association Statistics Committee and Stroke Statistics Subcommittee. Executive summary: heart disease and stroke statistics--2012 update: a report from the American Heart Association. Circulation. 2012; 125(1): 188–197.
  5. Montone RA, Niccoli G. Percutaneous coronary intervention in patients refused from surgery: a different entity? Minerva Cardioangiol. 2018 [Epub ahead of print].
  6. Hassan A, Buth KJ, Baskett RJF, et al. The association between prior percutaneous coronary intervention and short-term outcomes after coronary artery bypass grafting. Am Heart J. 2005; 150(5): 1026–1031.
  7. Thielmann M, Neuhäuser M, Knipp S, et al. Prognostic impact of previous percutaneous coronary intervention in patients with diabetes mellitus and triple-vessel disease undergoing coronary artery bypass surgery. J Thorac Cardiovasc Surg. 2007; 134(2): 470–476.
  8. Chocron S, Baillot R, Rouleau JL, et al. IMAGINE Investigators. Impact of previous percutaneous transluminal coronary angioplasty and/or stenting revascularization on outcomes after surgical revascularization: insights from the imagine study. Eur Heart J. 2008; 29(5): 673–679.
  9. Yap CH, Yan BP, Akowuah E, et al. Does prior percutaneous coronary intervention adversely affect early and mid-term survival after coronary artery surgery? JACC Cardiovasc Interv. 2009; 2(8): 758–764.
  10. Bugajski P, Greberski K, Kuzemczak M, et al. The impact of previous percutaneous coronary interventions on the course and clinical outcomes of coronary artery bypass grafting. Kardiol Pol. 2018 [Epub ahead of print].
  11. Taggart DP. Does prior PCI influence the clinical outcome of CABG? EuroIntervention. 2009; 5 Suppl D: D21–D24.
  12. Hofma SH, van der Giessen WJ, van Dalen BM, et al. Indication of long-term endothelial dysfunction after sirolimus-eluting stent implantation. Eur Heart J. 2006; 27(2): 166–170.
  13. Montone RA, Sabato V, Sgueglia GA, et al. Inflammatory mechanisms of adverse reactions to drug-eluting stents. Curr Vasc Pharmacol. 2013; 11(4): 392–398.
  14. Montone RA, Niccoli G, De Marco F, et al. Temporal Trends in Adverse Events After Everolimus-Eluting Bioresorbable Vascular Scaffold Versus Everolimus-Eluting Metallic Stent Implantation: A Meta-Analysis of Randomized Controlled Trials. Circulation. 2017; 135(22): 2145–2154.

Important: This website uses cookies. More >>

The cookies allow us to identify your computer and find out details about your last visit. They remembering whether you've visited the site before, so that you remain logged in - or to help us work out how many new website visitors we get each month. Most internet browsers accept cookies automatically, but you can change the settings of your browser to erase cookies or prevent automatic acceptance if you prefer.

By "Via Medica sp. z o.o." sp.k., Świętokrzyska 73 street, 80–180 Gdańsk, Poland

tel.:+48 58 320 94 94, faks:+48 58 320 94 60, e-mail: viamedica@viamedica.pl